Return to homepagePandemic Pact

Tocilizumab for Treatment of COVID-19 in intensive care patients ("TROCAR")

  • Funded by Medical Research Future Fund (MRFF)
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Known Financial Commitments (USD)

    $506,188.46

  • Funder

    Medical Research Future Fund (MRFF)

  • Principal Investigator

    N/A

  • Research Location

    Australia

  • Lead Research Institution

    QIMR Berghofer Medical Research Institute

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Unspecified

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

MRFF Respiratory Medicine Clinical Trials Research on COVID-19 Grant Opportunity research recipient